Steris shares drop on Q1 swing-and-miss, lowered outlook
Steris (NYSE:STE) posted Q1 results that missed the consensus forecast and reduced its outlook, despite swinging from a loss to a profit.
Source: massdevice.com
📰 Massdevice Medtech News
Page 28 - Massdevice Medtech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Massdevice Medtech. Real-time updates on events, politics, business and more.
Butterfly Network rises on Q2 results, will reduce workforce
Butterfly Network shares are up on Street-beating Q2 results, with the company announcing plans to modestly reduce its workforce.
Source: massdevice.com
AtriCure dips on mixed bag Q2
AtriCure shares took a slight hit today on second-quarter results that were mixed compared to the consensus forecast.
Source: massdevice.com
Siemens Healthineers sales down nearly 6% in Q3, but it sticks with outlook
Siemens Healthineers (ETR:SHL) shares are on the decline today upon the release of the company's third-quarter financial results.
Source: massdevice.com
Zimmer Biomet speeds up investments in NeuroOne
NeuroOne Medical Technologies will receive an accelerated $3.5 million milestone payment from Zimmer Biomet.
Source: massdevice.com
Fresenius Medical Care beats Street in Q2, cuts 2022 outlook
Fresenius Medical Care's Q2 results topped the consensus forecast, but the dialysis company cut its 2022 outlook.
Source: massdevice.com
Axonics stock ticks up on Street-beating Q2, increased guidance
Axonics' Q2 results also came in ahead of the consensus forecast, with the sacral neuromodulation tech company turning to TV advertising.
Source: massdevice.com
Zimmer Biomet scores a big earnings beat in Q2
Zimmer Biomet reported second-quarter results that handily beat the consensus forecast on Wall Street, upping its full-year forecast for 2022.
Source: massdevice.com
Neuronetics stock rises on Street-beating Q2
Neuronetics (Nasdaq:STIM) shares ticked up today on second-quarter results that beat the consensus forecast.
Source: massdevice.com
Outset Medical stock skyrockets on resumed Tablo shipments
Outset Medical shares are up big today despite second-quarter results that missed the consensus forecast.
Source: massdevice.com